Clinical Trial Services

Dec 14, 2016
By Pharmaceutical Technology Editors
BMS changes its US geographic footprint with R&D investments and closures.
Dec 08, 2016
At the American Society of Hematology Annual Meeting, Novartis and Kite Pharma both released results from early-phase clinical trials with CAR-T therapies.
Apr 01, 2016
BioPharm International
Demand is driving expansion and consolidation of formulation and clinical trial materials services.
Feb 02, 2016
By Pharmaceutical Technology Editors
Catalent plans a $4.6 million investment to expand secondary packaging and storage in Asia.
Feb 01, 2016
Pharmaceutical Technology
Only half of new drugs make it past Phase III. Adopting best practices and collaborating more closely with contract research organizations can help ensure success.
Feb 01, 2016
Pharmaceutical Technology
Mergers and acquisitions have changed the shape of the contract services market as big players seek to build full-service capabilities.
Feb 01, 2016
Pharmaceutical Technology
Steven Denham, director of biostatistics at MPI Research, discusses the impact the Standard for Exchange of Nonclinical Data may have on the pharmaceutical industry.
Sep 08, 2015
By Pharmaceutical Technology Editors
The partners will collaborate on a project to capture and integrate clinical trial data metrics on investigational cancer medications.
May 26, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
EMA confirms its recommendation to suspend medicines approved based on GVK Biosciences studies.
Apr 15, 2015
By Pharmaceutical Technology Editors
Pfizer announces that its Phase III trial for Ibrance met its primary endpoint and was ended early due to efficacy based on an assessment by an independent Data Monitoring Committee.
native1_300x100
lorem ipsum